What are the characteristics of INVENTIVA stock?

INVENTIVA is a company operating in the Santé · Biotechnologies · Vaccins et laboratoires de recherche sector. The stock is listed on Euronext Paris under ISIN FR0013233012.

What is the recent price evolution of INVENTIVA stock?

Since last close: -4.11 %. Over one week: -23.08 %. Over one year: 21.11 %.

Inventiva to Attend Four Investor Conferences in March

Inventiva announces its participation in four major investor conferences in March 2026. The biopharmaceutical company's management will be present for individual meetings and presentations to investors.

Published on Feb 27, 2026 at 08:10

INVENTIVA

3.50 € -4.11 %

Conference Schedule and Details

Inventiva will participate in the TD Cowen 46th Health Care Conference from March 2 to March 4, 2026, in Boston, Massachusetts, with a fireside chat scheduled for Monday, March 2 at 4:30 PM CET. The company will also be present at the Leerink Global Healthcare Conference from March 9 to March 11, 2026, in Miami, Florida, with a presentation on Tuesday, March 10 at 3:00 PM CET. Inventiva will take part in the Barclays 28th Global Healthcare Conference from March 10 to March 12, 2026, in Miami, Florida, with a fireside chat scheduled for Wednesday, March 11 at 4:00 PM CET. Additionally, the company will attend the UBS Biotech Conference: Catalyst for Change from March 8 to March 10, 2026, in Miami, Florida.

Webcast Availability

Free · Every morning

Technical market signals, before the opening bell.

Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.

✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis

Indicative data. No investment advice. Unsubscribe at any time.

The presentations and fireside chats will be webcast and can be accessed through the Investor Presentations section of Inventiva's website.

🏢 Other stocks — Santé

🗞️ Ipsen's Stock Rebounds Over 2%, Marking One of the Top Gains in SBF 120 🗞️ Valneva's Shares Continue to Fall, Threatening Key Support at €2.26 🗞️ DBV Technologies Shares Drop Nearly 4% Breaking Below 200-Day Moving Average 🗞️ Sanofi Shares Lead the CAC 40, Surpassing €78

Context

Period

Period: 1T2026

Key reported figures

Revenue: 0€

Risks mentioned

Aucune garantie que les bons de souscription seront exercés en totalité.
Inventiva a un historique d'exploitation limité et a subi des pertes importantes.

Opportunities identified

Estime que sa trésorerie lui permettra de financer ses activités jusqu'à la mi-premier trimestre 2027.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Conference Schedule and Details

Webcast Availability

Context

Also read